AAVnerGene is a leading biotech company specializing in the development of advanced gene therapy technologies utilizing the AAV platform. Situated in Rockville, Maryland, our state-of-the-art facilities span over 10,000 square feet housing dedicated spaces for research and development as well as production capabilities. With a leadership team boasting over two decades of experience in the field of AAV gene therapy, along with numerous publications and patents, we are at the forefront of innovation. Our objective is to enhance the accessibility of gene therapy by addressing the bottlenecks in AAV gene therapy.